NCT00196950View on ClinicalTrials.gov

Study to Evaluate Meningococcal Serogroups A,C,W-135,Y Conjugate Vaccine When Given as 1 Dose to Healthy Subjects Aged 18-25 Years

PHASE2CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

October 31, 2003

Study Completion Date

October 31, 2003

Conditions

Infections, Meningococcal

Interventions

BIOLOGICAL

Meningococcal (vaccine)

Trial Locations (1)

6041

GSK Investigational Site, Gosselies

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY